Influence of mycophenolate mofetil and calcineurine inhibitor differences on basiliximab pharmacokinetics in renal transplant patients.

被引：0
|
作者：
Haba, T [1 ]
Uchida, K [1 ]
Katayama, A [1 ]
Gotoh, N [1 ]
Tominaga, Y [1 ]
Matsuoka, O [1 ]
Satoh, T [1 ]
Uno, N [1 ]
Takeda, A [1 ]
Morozumi, K [1 ]
机构：
[1] Nagoya Daini Red Cross Hosp, Dept Transplantat Surg, Nagoya, Aichi, Japan
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2005年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
105
引用
收藏
页码：183 / 183
页数：1
相关论文
共 50 条
  • [1] Differential influence of azathioprine and mycophenolate mofetil on the disposition of basiliximab in renal transplant patients
    Kovarik, JM
    Pescovitz, MD
    Sollinger, HW
    Kaplan, B
    Legendre, C
    Salmela, K
    Book, BK
    Gerbeau, C
    Girault, D
    Somberg, K
    [J]. CLINICAL TRANSPLANTATION, 2001, 15 (02) : 123 - 130
  • [2] Pharmacokinetics and Immunodynamics of Basiliximab in Pediatric Renal Transplant Recipients on Mycophenolate Mofetil Comedication
    Hoecker, Britta
    Kovarik, John M.
    Daniel, Volker
    Opelz, Gerhard
    Fehrenbach, Henry
    Holder, Martin
    Hoppe, Bernd
    Hoyer, Peter
    Jungraithmayr, Therese C.
    Koepf-Shakib, Sabine
    Laube, Guido F.
    Mueller-Wiefel, Dirk E.
    Offner, Gisela
    Plank, Christian
    Schroeder, Monika
    Weber, Lutz T.
    Zimmerhackl, Lothar B.
    Toenshoff, Burkhard
    [J]. TRANSPLANTATION, 2008, 86 (09) : 1234 - 1240
  • [3] Benefit of mycophenolate mofetil in immunized renal transplant patients.
    Kliem, V
    vonWoellwarth, J
    Behrend, M
    Schlitt, HJ
    Nashan, B
    Koch, KM
    Pichlmayr, R
    Brunkhorst, R
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A3211 - A3211
  • [4] Pharmacokinetics of mycophenolate mofetil in eight pediatric renal transplant patients
    Aigrain, EJ
    Shaghaghi, EK
    Baudouin, V
    Popon, M
    Loirat, C
    [J]. TRANSPLANTATION PROCEEDINGS, 2000, 32 (02) : 388 - 390
  • [5] Pharmacokinetics, safety and efficacy of mycophenolate mofetil in combination with sirolimus vs cyclosporine in renal transplant patients.
    Pescovitz, M
    Vincenti, F
    Hart, M
    Melton, L
    Whelchel, J
    Mulgaonkar, S
    McKay, D
    Leung, M
    Calleja, E
    Ghahramani, P
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 251 - 251
  • [6] Pharmacokinetics of mycophenolate mofetil in kidney transplant patients with renal insufficiency
    González-Roncero, FM
    Gentil, MA
    Brunet, M
    Algarra, G
    Pereira, P
    Cabello, V
    Peralvo, M
    [J]. TRANSPLANTATION PROCEEDINGS, 2005, 37 (09) : 3749 - 3751
  • [7] Pharmacokinetics (PK) of intravenous mycophenolate mofetil (MMF) in liver transplant patients.
    Hebert, MF
    Chang, T
    Linna, TJ
    Hale, MD
    Roberts, JP
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (02) : PI101 - PI101
  • [8] Renal dysfunction in orthotopic liver transplant patients: A single center experience with calcineurine inhibitor dose reduction and introduction of mycophenolate mofetil.
    Mejzlik, V
    Studenik, P
    Kuman, M
    Ondrasek, J
    Cerny, J
    [J]. LIVER TRANSPLANTATION, 2005, 11 (07) : C42 - C42
  • [9] Rapid reduction of mycophenolate mofetil and calcineurin inhibitor dose for treating cytomegalovirus infection in renal transplant patients.
    Lin, Kuo Jen
    Wang, Hsu-Han
    Lin, Chih-Te
    Pan, Pai-Yen
    Chen, Sy-Yuan
    [J]. TRANSPLANTATION, 2024, 108 (09) : 592 - 592
  • [10] Pharmacokinetics and tolerance of mycophenolate mofetil in renal transplant children
    Jacqz-Aigrain, E
    Shaghaghi, EK
    Baudouin, V
    Popon, M
    Zhang, DL
    Maisin, A
    Loirat, C
    [J]. PEDIATRIC NEPHROLOGY, 2000, 14 (02) : 95 - 99
12345